BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Cho CK. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today. 2014;44:1879-1886. [PMID: 24535697 DOI: 10.1007/s00595-014-0846-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Skalicky P, Urban O, Ehrmann J, Svebisova H, Klos D, Tesarikova J, Neoral C, Knapkova K, Lovecek M. The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34467956 DOI: 10.5507/bp.2021.043] [Reference Citation Analysis]
2 Bednarsch J, Czigany Z, Heij LR, Liu D, den Dulk M, Wiltberger G, Bruners P, Ulmer TF, Neumann UP, Lang SA. Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma. J Clin Med 2021;10:2959. [PMID: 34209368 DOI: 10.3390/jcm10132959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chang WI, Kim BH, Kang HC, Kim K, Lee KH, Oh DY, Kim H, Kwon W, Jang JY, Chie EK. The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis. Int J Radiat Oncol Biol Phys 2021;111:395-404. [PMID: 34029643 DOI: 10.1016/j.ijrobp.2021.05.012] [Reference Citation Analysis]
4 Lee JW, Choi SB, Lim TW, Kim WJ, Park P, Kim WB. Prognostic value of the lymph node metastasis in patients with ampulla of Vater cancer after surgical resection. Ann Hepatobiliary Pancreat Surg 2021;25:90-6. [PMID: 33649260 DOI: 10.14701/ahbps.2021.25.1.90] [Reference Citation Analysis]
5 Chin KM, Di Martino M, Syn N, Ielpo B, Hilal MA, Goh BKP, Koh YX, Prieto M. Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review. Eur J Surg Oncol 2021;47:1267-77. [PMID: 33549378 DOI: 10.1016/j.ejso.2021.01.004] [Reference Citation Analysis]
6 Song BH, Cha B, Park JS, Jeong S, Lee DH. Effects of microvascular invasion on clinical outcomes after resection with curative intent for cholangiocarcinoma. Medicine (Baltimore) 2020;99:e23668. [PMID: 33350747 DOI: 10.1097/MD.0000000000023668] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ohgi K, Uesaka K. The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr 2021;40:3552-8. [PMID: 33358552 DOI: 10.1016/j.clnu.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kamarajah SK, Bednar F, Cho CS, Nathan H. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis. Cancer 2021;127:1266-74. [PMID: 33320344 DOI: 10.1002/cncr.33356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lyu S, Li L, Zhao X, Ren Z, Cao D, He Q. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy. World J Surg Oncol 2020;18:262. [PMID: 33032609 DOI: 10.1186/s12957-020-02040-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Syskova AY, Stilidi IS, Polyakov AN. PROGNOSTIC FACTORS FOR RESECTABLE COMMON BILE DUCT CANCER. Issled prakt med (Print) 2019;6:69-74. [DOI: 10.17709/2409-2231-2019-6-2-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Sha M, Cao J, Sun HY, Tong Y, Xia Q. Neuroendocrine regulation of cholangiocarcinoma: A status quo review. Biochim Biophys Acta Rev Cancer 2019;1872:66-73. [PMID: 31152820 DOI: 10.1016/j.bbcan.2019.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2019;45:1468-1478. [PMID: 31053477 DOI: 10.1016/j.ejso.2019.04.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
13 Li X, Lin H, Sun Y, Gong J, Feng H, Tu J. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma. J Surg Res 2019;236:2-11. [PMID: 30694756 DOI: 10.1016/j.jss.2018.10.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wiltberger G, Krenzien F, Atanasov G, Hau HM, Schmelzle M, Bartels M, Benzing C. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome? Acta Chir Belg 2018;118:341-7. [PMID: 30203717 DOI: 10.1080/00015458.2017.1385894] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Okumura Y, Noda T, Eguchi H, Sakamoto T, Iwagami Y, Yamada D, Asaoka T, Wada H, Kawamoto K, Gotoh K, Kobayashi S, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer. Ann Surg Oncol 2018;25:3728-37. [PMID: 30105440 DOI: 10.1245/s10434-018-6670-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
16 Zhou H, Xu J, Wang S, Peng J. Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines. Mol Med Rep 2018;17:7672-82. [PMID: 29620225 DOI: 10.3892/mmr.2018.8860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Hu J, Chen FY, Zhou KQ, Zhou C, Cao Y, Sun HC, Fan J, Zhou J, Wang Z. Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection. Oncotarget 2017;8:113817-27. [PMID: 29371948 DOI: 10.18632/oncotarget.22852] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
18 Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World J Gastroenterol 2017; 23(36): 6685-6693 [PMID: 29085213 DOI: 10.3748/wjg.v23.i36.6685] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
19 Songthamwat M, Chamadol N, Khuntikeo N, Thinkhamrop J, Koonmee S, Chaichaya N, Bethony J, Thinkhamrop B. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand. World J Surg Oncol 2017;15:176. [PMID: 28931405 DOI: 10.1186/s12957-017-1246-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Petrova E, Rückert F, Zach S, Shen Y, Weitz J, Grützmann R, Wittel UA, Makowiec F, Hopt UT, Bronsert P, Kühn F, Rau BM, Izrailov RE, Khatkov IE, Lapshyn H, Bolm L, Bausch D, Keck T, Wellner UF, Seifert G. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study. Langenbecks Arch Surg 2017;402:831-40. [PMID: 28612115 DOI: 10.1007/s00423-017-1590-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
21 Shimura T, Kofunato Y, Okada R, Yashima R, Koyama Y, Araki K, Kuwano H, Takenoshita S. Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett 2017;14:819-29. [PMID: 28693238 DOI: 10.3892/ol.2017.6252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Andrianello S, Marchegiani G, Malleo G, Rusev BC, Scarpa A, Bonamini D, Maggino L, Bassi C, Salvia R. Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer. J Gastrointest Surg 2017;21:527-33. [PMID: 27882511 DOI: 10.1007/s11605-016-3328-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Chua TC, Mittal A, Arena J, Sheen A, Gill AJ, Samra JS. Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg 2017;213:1072-6. [PMID: 27751529 DOI: 10.1016/j.amjsurg.2016.09.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution. Cancer Res Treat 2017;49:473-83. [PMID: 27554480 DOI: 10.4143/crt.2016.166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
25 Postlewait LM, Ethun CG, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, Cardona K, Maithel SK. Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18:793-9. [PMID: 27506989 DOI: 10.1016/j.hpb.2016.07.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today 2017;47:271-9. [DOI: 10.1007/s00595-016-1362-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
27 Sakamoto T, Kobayashi S, Yamada D, Nagano H, Tomokuni A, Tomimaru Y, Noda T, Gotoh K, Asaoka T, Wada H, Kawamoto K, Marubashi S, Eguchi H, Doki Y, Mori M. A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer. PLoS One 2016;11:e0145985. [PMID: 26726879 DOI: 10.1371/journal.pone.0145985] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
28 Wiltberger G, Krenzien F, Benzing C, Atanasov G, Klein F, Hau HM, Feldbrügge L, Pratschke J, Schmelzle M, Jonas S. Prognostic Accuracy of the Seventh Edition of the TNM Classification Compared with the Fifth and Sixth Edition for Distal Cholangiocarcinoma. Ann Surg Oncol 2016;23:1320-6. [PMID: 26607711 DOI: 10.1245/s10434-015-4999-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
29 Zhou Y, Liu S, Wu L, Wan T. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg. 2017;40:129-138. [PMID: 26337377 DOI: 10.1016/j.asjsur.2015.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
30 Andrianello S, Paiella S, Allegrini V, Ramera M, Pulvirenti A, Malleo G, Salvia R, Bassi C. Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbecks Arch Surg 2015;400:623-8. [DOI: 10.1007/s00423-015-1320-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
31 Zhang JW, Chu YM, Lan ZM, Tang XL, Chen YT, Wang CF, Che X. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(14): 4255-4260 [PMID: 25892876 DOI: 10.3748/wjg.v21.i14.4255] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]